CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement w.r.t to Q2 (2023-24) financial results is attached10-11-2023
10-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In continuation to our communication dated November 03, 2023, we would like to update that the audio recording of the Earnings Call for Q2/ FY 2023-24 held today, i.e. Thursday, November 09, 2023 at 17:30 hrs (IST) has been made available on the Company's website.09-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In continuation to our communication dated November 03, 2023, we would like to update that the audio recording of the Earnings Call for Q2/ FY 2023-24 held today, i.e. Thursday, November 09, 2023 at 17:30 hrs (IST) has been made available on the Company's website.09-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - September 30, 2023
Financial Results for QE 30-09-2023, press release and Investor presentation is attached09-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Financial Results For QE 30-09-2023
Financial Results for QE 30-09-2023 along with press release and investor presentation is attached09-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Change in the Contact person details for the Earnings Call scheduled on Thursday, November 9, 202303-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post-results conference call with the analyst's / fund houses/ investors to discuss the financial performance of the Company for the quarter and half year ended September 30, 202303-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Considering And Approving, Inter-Alia The Un-Audited Financial Results
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve the un-audited financial results of the Company for the quarter and half-year ended September 30, 2023 (both standalone & consolidated)01-11-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Resignation Of Senior Management Personnel ("SMP").
Please find attached the intimation regarding resignation of SMP30-10-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 202304-10-2023